APATINIB

Clinical trials for APATINIB explained in plain language.

Never miss a new study

Get alerted when new APATINIB trials appear

Sign up with your email to follow new studies for APATINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New combo therapy shows promise for incurable liver cancer

Disease control Recruiting now

This study tests whether adding immunotherapy (camrelizumab) and a targeted drug (apatinib) to a standard liver cancer treatment called TACE can help people with advanced liver cancer live longer without their cancer growing. About 101 adults with liver cancer that cannot be remo…

Matched conditions: APATINIB

Phase: PHASE3 • Sponsor: Guohui Xu • Aim: Disease control

Last updated Jun 15, 2026 19:02 UTC

APATINIB

Get alerted when new APATINIB trials appear

New combo therapy shows promise for incurable liver cancer